Cargando…

A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study

BACKGROUND: Approach bias modification (ApBM), a computerized cognitive intervention that trains people to “avoid” alcohol-related images and “approach” nonalcohol images, reduces the likelihood of relapse when administered during residential alcohol treatment. However, most individuals experiencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Manning, Victoria, Piercy, Hugh, Garfield, Joshua Benjamin Bernard, Clark, Stuart Gregory, Andrabi, Mah Noor, Lubman, Dan Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709909/
https://www.ncbi.nlm.nih.gov/pubmed/34890355
http://dx.doi.org/10.2196/31353
_version_ 1784623045903646720
author Manning, Victoria
Piercy, Hugh
Garfield, Joshua Benjamin Bernard
Clark, Stuart Gregory
Andrabi, Mah Noor
Lubman, Dan Ian
author_facet Manning, Victoria
Piercy, Hugh
Garfield, Joshua Benjamin Bernard
Clark, Stuart Gregory
Andrabi, Mah Noor
Lubman, Dan Ian
author_sort Manning, Victoria
collection PubMed
description BACKGROUND: Approach bias modification (ApBM), a computerized cognitive intervention that trains people to “avoid” alcohol-related images and “approach” nonalcohol images, reduces the likelihood of relapse when administered during residential alcohol treatment. However, most individuals experiencing alcohol problems do not require, do not seek, or have difficulty accessing residential treatment. Smartphone-delivered ApBM could offer an easily accessible intervention to reduce alcohol consumption that can be personalized (eg, allowing selection of personally relevant alcohol and positive nonalcohol training images) and gamified to optimize engagement. OBJECTIVE: We examined the feasibility, acceptability, and preliminary effectiveness of “SWiPE,” a gamified, personalized alcohol ApBM smartphone app, and explored alcohol consumption and craving outcomes in people drinking at hazardous levels or above (Alcohol Use Disorders Identification Test [AUDIT] score ≥8) who wanted to reduce their alcohol use. METHODS: In this open-label trial, frequency and quantity of alcohol consumption, alcohol dependence severity, and craving were measured prior to participants downloading SWiPE. Participants (n=1309) were instructed to complete at least 2 sessions per week for 4 weeks. Recruitment and completion rates were indicators of feasibility. Functionality, aesthetics, and quality ratings were indicators of acceptability. Participants were prompted to report frequency and quantity of alcohol consumption weekly during training and 1 month after training. They completed measures of craving and dependence after 4 weeks of training. RESULTS: We recruited 1309 participants (mean age 47.0, SD 10.0 years; 758/1309, 57.9% female; mean AUDIT score 21.8, SD 6.5) over 6 months. Participants completed a median of 5 sessions (IQR 2-9); 31.2% (409/1309) completed ≥8 sessions; and 34.8% (455/1309) completed the posttraining survey. Mean Mobile Application Rating Scale scores indicated good acceptability for functionality and aesthetics and fair acceptability for subjective quality. Among those who completed the posttraining assessment, mean past-week drinking days reduced from 5.1 (SD 2.0) pre-training to 4.2 (SD 2.3) in week 4 (t(454)=7.87; P<.001), and mean past-week standard drinks reduced from 32.8 (SD 22.1) to 24.7 (SD 20.1; t(454)=8.58; P<.001). Mean Craving Experience Questionnaire frequency scores reduced from 4.5 (SD 2.0) to 2.8 (SD 1.8; t(435)=19.39; P<.001). Severity of Dependence scores reduced from 7.7 (SD 3.0) to 6.0 (SD 3.2; t(435)=12.44; P<.001). For the 19.4% (254/1309) of participants who completed a 1-month follow-up, mean past-week drinking days and standard drinks were 3.9 (SD 2.5) and 23.9 (SD 20.7), respectively, both significantly lower than at baseline (P<.001). CONCLUSIONS: The findings suggest SWiPE is feasible and acceptable and may be effective at reducing alcohol consumption and craving in a predominantly nontreatment-seeking sample of adult Australians drinking at hazardous levels. SWiPE’s efficacy, relative to a control condition, now needs establishing in a randomized controlled trial. Smartphone-delivered personalized ApBM could be a highly scalable, widely accessible support tool for reducing alcohol use. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12620000638932; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12620000638932p INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/21278
format Online
Article
Text
id pubmed-8709909
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-87099092022-01-10 A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study Manning, Victoria Piercy, Hugh Garfield, Joshua Benjamin Bernard Clark, Stuart Gregory Andrabi, Mah Noor Lubman, Dan Ian JMIR Mhealth Uhealth Original Paper BACKGROUND: Approach bias modification (ApBM), a computerized cognitive intervention that trains people to “avoid” alcohol-related images and “approach” nonalcohol images, reduces the likelihood of relapse when administered during residential alcohol treatment. However, most individuals experiencing alcohol problems do not require, do not seek, or have difficulty accessing residential treatment. Smartphone-delivered ApBM could offer an easily accessible intervention to reduce alcohol consumption that can be personalized (eg, allowing selection of personally relevant alcohol and positive nonalcohol training images) and gamified to optimize engagement. OBJECTIVE: We examined the feasibility, acceptability, and preliminary effectiveness of “SWiPE,” a gamified, personalized alcohol ApBM smartphone app, and explored alcohol consumption and craving outcomes in people drinking at hazardous levels or above (Alcohol Use Disorders Identification Test [AUDIT] score ≥8) who wanted to reduce their alcohol use. METHODS: In this open-label trial, frequency and quantity of alcohol consumption, alcohol dependence severity, and craving were measured prior to participants downloading SWiPE. Participants (n=1309) were instructed to complete at least 2 sessions per week for 4 weeks. Recruitment and completion rates were indicators of feasibility. Functionality, aesthetics, and quality ratings were indicators of acceptability. Participants were prompted to report frequency and quantity of alcohol consumption weekly during training and 1 month after training. They completed measures of craving and dependence after 4 weeks of training. RESULTS: We recruited 1309 participants (mean age 47.0, SD 10.0 years; 758/1309, 57.9% female; mean AUDIT score 21.8, SD 6.5) over 6 months. Participants completed a median of 5 sessions (IQR 2-9); 31.2% (409/1309) completed ≥8 sessions; and 34.8% (455/1309) completed the posttraining survey. Mean Mobile Application Rating Scale scores indicated good acceptability for functionality and aesthetics and fair acceptability for subjective quality. Among those who completed the posttraining assessment, mean past-week drinking days reduced from 5.1 (SD 2.0) pre-training to 4.2 (SD 2.3) in week 4 (t(454)=7.87; P<.001), and mean past-week standard drinks reduced from 32.8 (SD 22.1) to 24.7 (SD 20.1; t(454)=8.58; P<.001). Mean Craving Experience Questionnaire frequency scores reduced from 4.5 (SD 2.0) to 2.8 (SD 1.8; t(435)=19.39; P<.001). Severity of Dependence scores reduced from 7.7 (SD 3.0) to 6.0 (SD 3.2; t(435)=12.44; P<.001). For the 19.4% (254/1309) of participants who completed a 1-month follow-up, mean past-week drinking days and standard drinks were 3.9 (SD 2.5) and 23.9 (SD 20.7), respectively, both significantly lower than at baseline (P<.001). CONCLUSIONS: The findings suggest SWiPE is feasible and acceptable and may be effective at reducing alcohol consumption and craving in a predominantly nontreatment-seeking sample of adult Australians drinking at hazardous levels. SWiPE’s efficacy, relative to a control condition, now needs establishing in a randomized controlled trial. Smartphone-delivered personalized ApBM could be a highly scalable, widely accessible support tool for reducing alcohol use. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12620000638932; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12620000638932p INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/21278 JMIR Publications 2021-12-10 /pmc/articles/PMC8709909/ /pubmed/34890355 http://dx.doi.org/10.2196/31353 Text en ©Victoria Manning, Hugh Piercy, Joshua Benjamin Bernard Garfield, Stuart Gregory Clark, Mah Noor Andrabi, Dan Ian Lubman. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 10.12.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Manning, Victoria
Piercy, Hugh
Garfield, Joshua Benjamin Bernard
Clark, Stuart Gregory
Andrabi, Mah Noor
Lubman, Dan Ian
A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study
title A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study
title_full A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study
title_fullStr A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study
title_full_unstemmed A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study
title_short A Personalized Approach Bias Modification Smartphone App (“SWiPE”) to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study
title_sort personalized approach bias modification smartphone app (“swipe”) to reduce alcohol use: open-label feasibility, acceptability, and preliminary effectiveness study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709909/
https://www.ncbi.nlm.nih.gov/pubmed/34890355
http://dx.doi.org/10.2196/31353
work_keys_str_mv AT manningvictoria apersonalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT piercyhugh apersonalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT garfieldjoshuabenjaminbernard apersonalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT clarkstuartgregory apersonalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT andrabimahnoor apersonalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT lubmandanian apersonalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT manningvictoria personalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT piercyhugh personalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT garfieldjoshuabenjaminbernard personalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT clarkstuartgregory personalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT andrabimahnoor personalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy
AT lubmandanian personalizedapproachbiasmodificationsmartphoneappswipetoreducealcoholuseopenlabelfeasibilityacceptabilityandpreliminaryeffectivenessstudy